SCHEMBL1662466

SCHEMBL1662466

O=c1cc(Cc2ccc3ccccc3c2)[nH]c2n[nH]c(C3=CC=C3)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.37
EGFR P00533 1/20 0.36
FLT1 P17948 1/20 0.36
MPO P05164 1/20 0.34
DAO P14920 3/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
BACE1 P56817 1/20 0.33
PDE10A Q9Y233 2/20 0.32
ADORA2A P29274 1/20 0.32
CTRC Q99895 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALKBH3 Q96Q83 1/20 0.32
CLPP Q16740 1/20 0.32
GLO1 Q04760 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1662359 0.87 ADORA1 (0.40) ADORA1EGFRMPODAOKDM4E
SCHEMBL1665156 0.83 KDM4A (0.37) ADORA1EGFRDAOADORA2AALDH1A1
SCHEMBL1664770 0.74 CCNB2 (0.37) ADORA1EGFRFLT1DAOCYP2D6
SCHEMBL1664721 0.74 CCNB2 (0.37) ADORA1EGFRFLT1DAOCYP2D6
SCHEMBL1662550 0.74 CCNB2 (0.35) ADORA1EGFRFLT1DAOCYP2D6
Hydrochloric Acid SCHEMBL4714306 0.65 JAK1 (0.59) ADORA1ADORA2AKDM4EALDH1A1TP53
SCHEMBL1662357 0.62 CDK2 (0.43) ADORA1EGFRDAOKDM4EALDH1A1
SCHEMBL6991892 0.62 LOXL2 (0.55) CYP2D6NFKB1TAAR1
SCHEMBL2838141 0.60 CYP1A2 (0.65) CYP2D6NFKB1TAAR1CTRC
Hydrochloric Acid SCHEMBL4714406 0.59 KDM4E (0.38) KDM4EALDH1A1TP53HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120220624-A1 PYRAZOLO [3,4-B] PYRIDIN-4-ONE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2012-08-30 US claimed
US-20120220624-A1 PYRAZOLO [3,4-B] PYRIDIN-4-ONE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2012-08-30 US disclosed
EP-2490693-A1 PYRAZOLO [3,4-b]PYRIDIN-4-ONE KINASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2012-08-29 EP disclosed
WO-2011049722-A1 PYRAZOLO [3,4-b] PYRIDIN-4-ONE KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220624-A1 PYRAZOLO [3,4-B] PYRIDIN-4-ONE KINASE INHIBITORS CDK1, CDK5, TTBK1 ADORA1 2411/4885EGFR 612/4885FLT1 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.